Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-CD26/DPP4 Polyclonal Antibody

Catalog #:   PHD74101 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P27487
Overview

Catalog No.

PHD74101

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human CD26/DPP4 (Thr401-Thr746).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

TP103,Dipeptidyl peptidase IV,ADABP,Dipeptidyl peptidase 4,CD26,DPP4,Dipeptidyl peptidase IV soluble form,Dipeptidyl peptidase IV membrane form,DPP IV,ADCP2,Adenosine deaminase complexing protein 2,ADCP-2,T-cell activation antigen CD26

Purification

Purified by antigen affinity column.

Accession

P27487

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • WESTERN BLOT
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with CD26/DPP4 antibody (PHD74101) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 42 kDa
    Observed MW: 42 kDa
References

Targeting the senescent surfaceome through DPP4 antibody-functionalized nanoparticles. An application to cancer therapy., PMID:40494025

Development of DPP-4-resistant CXCL9-Fc and CXCL10-Fc chemokines for effective cancer immunotherapy., PMID:40238455

Anti-S2 antibodies responsible for the SARS-CoV-2 infection-induced serological cross-reactivity against MERS-CoV and MERS-related coronaviruses., PMID:40226608

ACE2 utilization of HKU25 clade MERS-related coronaviruses with broad geographic distribution., PMID:40162213

Gastroprotective Effect of Linagliptin on Indomethacin-Induced Gastric Ulceration in Mice: Crosstalk Between Oxidative Stress and Inflammasome Pathways., PMID:40109745

ACE2 utilization of HKU25 clade MERS-related coronaviruses with broad geographic distribution., PMID:40027745

Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses., PMID:39922192

Bullous pemphigoid: A practical approach to diagnosis and management in the modern era., PMID:39914667

Dipeptidyl peptidase 4 is a cofactor for porcine epidemic diarrhea virus infection., PMID:39765007

Vitamin D Supplementation as a Therapeutic Strategy in Autoimmune Diabetes: Insights and Implications for LADA Management., PMID:39683465

Detection and Evaluation of Procalcitonin Variants As Diagnostic Tools in Systemic Inflammation., PMID:39636188

Design of a Magnetic Nanoplatform Based on CD26 Targeting and HSP90 Inhibition for Apoptosis and Ferroptosis-Mediated Elimination of Senescent Cells., PMID:39631769

Metabolic Consequences of Glucagon-Like Peptide-1 Receptor Agonist Shortage: Deterioration of Glycemic Control in Type 2 Diabetes., PMID:39582250

Effect of switching from dulaglutide to tirzepatide on blood glucose and renal function., PMID:39462543

Clinical characteristics and outcomes of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid patients: A retrospective study., PMID:39442884

Serum interleukin-10 level is increased and correlated positively with disease severity in patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid., PMID:39428667

Cold-adapted live attenuated MERS-CoV vaccine strain remains attenuated in mice after multiple passages in Vero cells at 37 °C., PMID:39240318

Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge., PMID:39189731

A Retrospective Comparison of Diagnostic Tools of Bullous Pemphigoid for Elderly Patients., PMID:39108027

Association between glucose-lowering drugs and circulating insulin antibodies induced by insulin therapy in patients with type 2 diabetes., PMID:39099829

Peptide array screening with anti-GLP-1 monoclonal antibody: Discovery of cysteine-containing DPP-IV inhibitory peptides., PMID:39085020

CD38/NAD+ glycohydrolase and associated antigens in chronic lymphocytic leukaemia: From interconnected signalling pathways to therapeutic strategies., PMID:39009062

Soluble CD26: From Suggested Biomarker for Cancer Diagnosis to Plausible Marker for Dynamic Monitoring of Immunotherapy., PMID:39001488

Phenotypic characterisation of bovine alveolar macrophages reveals two major subsets with differential expression of CD163., PMID:38951667

ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB., PMID:38915783

A case of immunoglobulin G4-related kidney disease manifesting after dipeptidyl peptidase-4 inhibitor treatment., PMID:38801515

Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review., PMID:38753071

Boosting humoral and cellular immunity with enhanced STING activation by hierarchical mesoporous metal-organic framework adjuvants., PMID:38723671

A dual-targeting approach using a human bispecific antibody against the receptor-binding domain of the Middle East Respiratory Syndrome Coronavirus., PMID:38697296

Inactivated Split MERS-CoV Antigen Prevents Lethal Middle East Respiratory Syndrome Coronavirus Infections in Mice., PMID:38675818

DPP Inhibition Enhances the Efficacy of PD-1 Blockade by Remodeling the Tumor Microenvironment in Lewis Lung Carcinoma Model., PMID:38672409

ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants: a quick therapeutic option for current and future coronaviruses outbreaks., PMID:38371953

HDAC Inhibition Induces CD26 Expression on Multiple Myeloma Cells via the c-Myc/Sp1-mediated Promoter Activation., PMID:38284882

Single-cell atlas of human infrapatellar fat pad and synovium implicates APOE signaling in osteoarthritis pathology., PMID:38266107

Association of COVID with Mycosis in General., PMID:38251692

A case of anti-laminin γ1 (p200) pemphigoid developed after dipeptidyl peptidase-4 inhibitor administration., PMID:38214494

Novel Pharmacological Treatment Options of Steroid-Refractory Graft-versus-Host Disease., PMID:38094101

From Molecular Insights to Clinical Perspectives in Drug-Associated Bullous Pemphigoid., PMID:38069109

In Doxorubicin-Adapted Hodgkin Lymphoma Cells, Acquiring Multidrug Resistance and Improved Immunosuppressive Abilities, Doxorubicin Activity Was Enhanced by Chloroquine and GW4869., PMID:38067159

A self-assembled graphene oxide adjuvant induces both enhanced humoral and cellular immune responses in influenza vaccine., PMID:38036004

Ocular cicatricial pemphigoid following Dipeptidyl Peptidase-4 inhibitor use: A case report., PMID:38035149

A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus., PMID:37756379

Dipeptidyl peptidase-4 inhibitor-related pemphigus herpetiformis with antibodies against desmocollin 3., PMID:37680081

Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies., PMID:37626869

Comprehensive cell surface protein profiling of human mesenchymal stromal cells from peritoneal dialysis effluent and comparison with those from human bone marrow and adipose tissue., PMID:37603218

Discovery of novel thymidylate synthase (TS) inhibitors that influence cancer angiogenesis and metabolic reprogramming in NSCLC cells., PMID:37437348

Analysis of IL-10 and IL-35 in dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid., PMID:37424368

The serum concentration and activity of DPP4 is positively related with the severity of hyperthyroidism in patients with Graves' disease., PMID:37350750

Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients., PMID:37170241

Dipeptidyl peptidase 4 inhibitor reduces tumor-associated macrophages and enhances anti-PD-L1-mediated tumor suppression in non-small cell lung cancer., PMID:37115489

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CD26/DPP4 Polyclonal Antibody [PHD74101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only